“Cautiously optimistic, and cautiously ecstatic." People involved in successful #Alzheimers clinical trial share their feelings.
STAT
@statnews
Reporting from the frontiers of health & medicine.
Sign up for any of our 10 free newsletters here: statnews.com/signup
STAT’s Tweets
Up and down the ladder: The latest comings and goings
1
2
A must-read article on what's been happening behind closed doors at BIO, from .
She details staff turnover, tension between Michelle McMurray-Heath and BIO's board chair Paul Hastings, and a confidential job assessment.
3
6
EXCLUSIVE: The inside story of Michelle McMurry-Heath’s departure from BIO, world's largest biotech trade group: Firings, internal clashes, and a pivotal job review.
By
statnews.com/2022/10/21/ins via
4
2
NEW: The abrupt departure of the CEO of the biotech lobby shocked the industry. I found internal tumult at the organization under Michelle McMurry-Heath's tenure included internal clashes, abrupt firings, and a bad morale report by McKinsey
5
7
EXCLUSIVE: Inside Michelle McMurry-Heath’s departure from BIO: Firings, internal clashes, and a pivotal job review
1
3
Opinion: Employed physicians will have a strong say regarding their professional futures. By exercising their growing market power, they will determine which potential employers deserve their loyalty.
1
4
“I would be lying to you if [I said] it doesn’t keep me up at night worrying that there is a certain chance that we may have to deploy another booster…”
interviews the FDA’s Peter Marks.
4
13
40
Data sharing is essential to our modern medical system. How do we make we build an ecosystem where it happens both effectively and ethically? Learn more about our next virtual event: trib.al/KJwZjNg #STATChats #healthdata
read image description
ALT
1
3
9
Opinion: The regulatory process may seem overwhelming and unnecessary for digital health innovators but working with regulators throughout the development of a product can lead to positive health and economic outcomes.
1
1
3
In 2023, the majority of marketing budgets are expected to go towards reaching one key audience: physicians and specialists. Get more insights like this in our free Pulse Check report: trib.al/EgHDesK #STATPulseCheck
1
1
Get a Ph.D. in health policy — from a single Powerpoint slide.
1
Are workplaces taking a toll on Americans' health? Recent surveys show 81% of workers will seek future employment where #mentalhealth is supported. Read more:
1
3
Racial disparities in neonatal mortality even wider with tools like IVF
1
1
How patient data are traded will determine the future of research and innovation in health care. Please join us for a discussion on Oct. 26 about how to create a better-functioning, more transparent system of data exchange.
You can sign up here:
1
2
3
Opinion: Research funding is broken. Using a lottery approach could fix it
3
6
Medicare is going to cap patients’ spending on drugs. But there’s no such limit for hospital or doctor bills
1
3
6
Opinion: Support family caregivers to improve and diversify clinical trials
3
5
Opinion: For the FDA, the coin of the realm is the trust the public holds in the agency — trust that it will safeguard the public’s health while approving the drugs necessary to fight disease safely and effectively.
Tobacco companies shower Black Democrats with campaign cash.
5
8
Dozens of institutional investors urge drugmakers to link executive compensation to access to medicines
1
1
BU’s Covid tinkering, FDA on trial, & why it’s hard to take drugs off the market
2
“It creates a clear pathway for the innovators, the manufacturers, and their investors to be like, oh, OK, this is what we need to do,” said of .
2
4
“As we recover from the worst of the pandemic, we have an opportunity and the power to make workplaces engines for mental health and well-being,” Surgeon General Vivek Murthy said in a statement. Story from
2
3
Novartis agrees to license a best-selling cancer drug to dozens of low- and middle-income countries
1
3
9
What are the long-term consequences of #monkeypox? Health professionals treating men struggle to answer.
1
2
As #AI models move further into #healthcare, hopes studies like the one he and his colleagues recently published will help support the scientific backing for the models.
5
3
A bold move by to cover prescription digital therapies when many others have shied away for lack of clear evidence.
Will it prove prescient or premature?
Great coverage from , via :
statnews.com/2022/10/19/hig via
2
6
It's #WorldCRISPRDay and we're offering access to our exclusive data tool, #CRISPR Trackr, and more for $30 for your first 3 months. Learn more: trib.al/pR2p8lw
GIF
#Flu transmission has been low since the start of the pandemic, but an odd spurt of activity in April, May, and June of 2022 suggests that flu may be making its way back.
4
4
1
6
6
I'll be at #ASHG22 next week, writing a newsletter about it w/ . Let us know which sessions, events and presentations are on your must-attend list.
And you can sign up for the newsletter here (last row):
4
3
‘Front of the line’: For Alzheimer’s patients in successful trial, a feeling of gratitude statnews.com/2022/10/20/fro STAT reporter spoke with people who participated in the lecanemab clinical trial, and their family members.
1
8
13
“This [is the] sort of study that people in my field dream about when we’re doing our Ph.D.s,” said Paul Norman, an associate professor of biomedical informatics at
3
9
Don't miss this opportunity to hear from some of health care's greatest minds. Register now:
1
1
Show this thread
The research done by Nora Volkow of has changed the way scientists think about addiction. Hear her talk about the addiction epidemic with STAT's
1
Show this thread
. raised eyebrows with a plan to create medicines that work by regenerating bodies deteriorating with age. CEO Hal Barron will talk with STAT's
1
3
Show this thread
Show this thread







